Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (651-660 of 710) with videos related to

Pageof 71
Sort By:
Human Mutation|September 8, 2011
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionMd Talat Nasim, Takeshi Ogo, Mohammad Ahmed, et al.
Circulation|September 24, 2013
Right ventricular diastolic impairment in patients with pulmonary arterial hypertensionSilvia Rain, M Louis Handoko, Pia Trip, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
Circulation|August 30, 2019
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal TransformationWen Tian, Xinguo Jiang, Yon K Sung, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 21, 2022
Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort studyAmélie Rivière, Clément Picard, Cristina Berastegui, et al.
Human Mutation|September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsRajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
The European Respiratory Journal|September 3, 2016
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
Pageof 71

Showing results (651-660 of 710) with videos related to

Sort By:
Pageof 71
Human Mutation|September 8, 2011
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionMd Talat Nasim, Takeshi Ogo, Mohammad Ahmed, et al.
Circulation|September 24, 2013
Right ventricular diastolic impairment in patients with pulmonary arterial hypertensionSilvia Rain, M Louis Handoko, Pia Trip, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
Circulation|August 30, 2019
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal TransformationWen Tian, Xinguo Jiang, Yon K Sung, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 21, 2022
Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort studyAmélie Rivière, Clément Picard, Cristina Berastegui, et al.
Human Mutation|September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsRajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial HypertensionLars Harbaum, Christopher J Rhodes, John Wharton, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
The European Respiratory Journal|September 3, 2016
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
Pageof 71